Blogs

Dr. Rosevear shares his insights in taking the boards. "As far as rites of passage go, taking the urology boards turned out to be relatively benign. There were no hot coals involved. Read more.

Other highly read UT articles this month include a large comparison of robotic and open RP, answers to your questions about coding for prostate biopsy, and several studies about risks for low and high T.

The use of PSA is not straightforward. It’s not simple or easy. But the last time I checked, we physicians went to school for a long time so that we could explain complicated problems to our patients.

Catch up on February’s best-read Urology Times articles, including our coverage of the AUA’s recent statement on NPs/PAs, a malpractice case involving removal of a cancer-free testicle, and a Q&A on diversity in urology.

In this blog post, Dr. Henry Rosevear ponders the relationship between drug reps and urologists.

Read and learn from Henry Rosevear, MD who experienced first hand how falls in the elderly are common and serious.

Urology Times looks back on the top health policy and practice management stories of 2014, including coverage of the Affordable Care Act and changes in reimbursement.

In this blog post, Henry Rosevear, MD, challenges thought leaders to offer guidance on the proper radiographic evaluation of new-onset colicky flank pain.

Have you ever “Googled” yourself? If you haven't, try it. The results may surprise you. Simply type your name into Google or another search engine, hit search, and see what pops up. Not all of it is pretty.

I was driving home from the office last week and realized that I have now been in the "real world" for over a year. As I looked back on the last year, I thought I would share a few of the lessons I've learned as I am curious if others have had a similar experience during their transition from residency to private practice.

As health care providers, our prime directive is to help our patients. Unfortunately, this altruism does not exempt us from the possibility of a violent act by a patient against us or our staff.

I consider urology to be a very unique field, one that I am lucky to be part of. Recently, though, I have begun to wonder whether the medical community (not necessarily the urology community) has been too quick to embrace the widespread use of testosterone replacement therapy.

Dr. Henry Rosevear’s blog post about my recently published book, “The Great Prostate Hoax: How big medicine hijacked the PSA test and caused a public health disaster,” does a disservice to the readership of the Urology Times by mischaracterizing the book’s central message.

Prostate cancer will not go away if we simply stop looking for it.

In his latest blog post, Henry Rosevear, MD, summarizes the Affordable Care Act and explains how it has already affected his practice.

In the first installment of a two-part series, Dr. Henry Rosevear examines how America established its current health insurance system, both private and public.

Urology Times is pleased to welcome Henry Rosevear, MD, to the publication’s Clinical Practice Board.

Blogger Henry Rosevear, MD, discusses lessons learned from his first experience in the OR while on his own when things did not go exactly as planned.

When we close the exam room door and sit down to speak with a patient, we are entering into a special covenant protected by law and at the backbone of building patient-provider rapport.

Residency is tough. Despite my chairman’s admonition that everything a resident needs to know is in “Campbell-Walsh Urology,” the text is missing at least one lesson, namely, how to find a job.

Let’s continue to work together to build this critically important, collaborative association between physician assistants and urologists.

New Urology Times blogger Kevin Wayne, PA-C charts his path to becoming a urology physician assistant.